Honest, Authentic, Truthful Leadership – Pravin Chaturvedi

In this episode, you'll hear from a serial biotech entrepreneur and incredible leader Pravin Chaturvedi. Many insightful words I kept with me from this episode as a leader in healthcare: Strive to Impact, not Impress. Life is short when you're happy, long when you're suffering. Never tolerate oppression of any form. Residual intellect. Powerpoint is useless :). Hear more about those leadership beliefs Pravin shared with us and also his experience in building biotech companies and teams. He left us with a powerful charge as healthcare leaders: "Never forget our huge responsibility: Patients rely on us to make their life better." If this is not why you wake up every morning and strive for, you're in the wrong industry.

"Hope is not a strategy to solve problems."

MEET OUR GUEST Pravin Chaturvedi Co-Founder & CEO at Oceanyx Pharmaceuticals.

Pravin Chaturvedi is a veteran drug developer, serial biotech entrepreneur, and seasoned CEO. CSO and/or Board member of many life science ventures. Over his 30+ years in the biotech and pharmaceutical industry, he has participated in and led the drug development teams for multiple drugs across the therapeutic areas of central nervous system (CNS), HIV, hepatitis C virus (HCV), cancer, and gastrointestinal disorders. He has participated in the successful drug approval and commercialization of seven drugs.

Pravin serves as the Chairman of the Scientific Advisory Board (SAB) and Chief Scientific Officer (CSO) for Napo Pharmaceuticals and Jaguar Health. He is also the co-founder and CEO of IndUS Pharmaceuticals and Oceanyx Pharmaceuticals. He is also the Executive Chairman of Cellanyx and Chair of the Board for Enlivity. He currently serves on the boards of several organizations including IndUS, Oceanyx, Cellanyx, Enlivity, and Sindu Research Laboratories. He has previously served as the President, CEO, and Board of Director for Pivot Pharmaceuticals and Scion Pharmaceuticals and has also served on the boards of Pivot, Scion, Bach Pharma, PRADAN USA, FuelEd Schools, Sindu Pharmaceuticals, TiE Boston, and ResoluteBio. Over his career, he has also been a part of multiple national and international strategic partnerships with large pharmaceutical companies as well as governments and has served on several advisory boards.

Prior to his current leadership responsibilities as (President/CEO/CSO roles in various companies), he served as the Head of Lead Evaluation at Vertex Pharmaceuticals. He held scientific positions at Alkermes and Parke-Davis/Warner-Lambert (now Pfizer). He also contributes significant time to teaching and serves as an adjunct faculty member at Georgetown Medical School. He holds a doctoral degree from West Virginia University and an undergraduate degree in pharmacy from the University of Bombay.